Balakumaran, J., Birk, T., Golemiec, B., Helmeczi, W., Inkaran, J., Kao, Y., . . . Samaan, M. C. (2019). Evaluating the endometabolic and bone health effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: A systematic review protocol. BMJ Open.
Citação norma ChicagoBalakumaran, Janatani, et al. "Evaluating the Endometabolic and Bone Health Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: A Systematic Review Protocol." BMJ Open 2019.
MLA citiranjeBalakumaran, Janatani, et al. "Evaluating the Endometabolic and Bone Health Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: A Systematic Review Protocol." BMJ Open 2019.
Opozorilo: Ti citati niso vedno 100% točni.